A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose

A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose

Background: Hepatic encephalopathy can be reversed by correcting precipitating factors and efficiently managed by lactulose and or rifaximin. Aims and Objective: The aim of this study to compare the effectiveness of three different modes of treatment in our study populations. Materials and Met...

Full description

Bibliographic Details
Main Authors: Uttam Biswas, Shyamal Kanti Pal, Pallabi Ray Chaudhuri, Debanjan Roychowdhury, Abhranil Dhar, Anirudhdha Roy
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2021-03-01
Series:Asian Journal of Medical Sciences
Subjects:
decompensated chronic liver diseases
hepatic encephalopathy
rifaximin
lactulose
mortality
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/32808

Similar Items

Similar Items